DR. REDDY’S LABORATORIES LIMITED Bank Overdrafts Classified As Cash Equivalents
DR. REDDY’S LABORATORIES LIMITED (RDY) had Bank Overdrafts Classified As Cash Equivalents of INR 61.00 million as of 2025-03-31, per its 20-F filed 2025-06-06.
Financial Statements › Notes
ifrs-full:BankOverdraftsClassifiedAsCashEquivalents · last filed 2025-06-06
- 2025-03-31: Bank Overdrafts Classified As Cash Equivalents 61.00M INR.
- 2024-03-31: Bank Overdrafts Classified As Cash Equivalents 0.00 INR.
- 2022-03-31: Bank Overdrafts Classified As Cash Equivalents 0.00 INR.
- 2021-03-31: Bank Overdrafts Classified As Cash Equivalents 9.00M INR.
INR
| Period end | Bank Overdrafts Classified As Cash Equivalents |
|---|---|
| 2025-03-31 | 61.00M INR 20-F · filed 2025-06-06 |
| 2024-03-31 | 0.00 INR 20-F · filed 2025-06-06 |
| 2022-03-31 | 0.00 INR 20-F · filed 2022-06-27 |
| 2021-03-31 | 9.00M INR 20-F · filed 2022-06-27 |
| 2020-03-31 | 91.00M INR 20-F · filed 2021-06-30 |
| 2019-03-31 | 0.00 INR 20-F · filed 2020-06-15 |
| 2018-03-31 | 96.00M INR 20-F · filed 2019-06-03 |
| 2017-03-31 | 87.00M INR 20-F · filed 2018-07-12 |
USD
| Period end | Bank Overdrafts Classified As Cash Equivalents |
|---|---|
| 2022-03-31 | $0.00 20-F · filed 2022-06-27 |
| 2021-03-31 | $0.00 20-F · filed 2021-06-30 |
| 2020-03-31 | $1.00M 20-F · filed 2020-06-15 |
| 2019-03-31 | $0.00 20-F · filed 2019-06-03 |
| 2018-03-31 | $1.00M 20-F · filed 2018-07-12 |